Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Salugna Banerjee
University of Miami School of Medicine, Department: Surgery
Should you be removed from our database? Contact us at [email protected]. Read more below.
Minneamrita Therapeutics
Salary not from the awardee Institution
Dr. Banerjee is a compensated consultant for Minneamrita, which directly overlaps with her sponsored research.
Role of HSP70 in Pancreatic Diseases
Narrative We have previously shown that HSP-70, a chaperone protein, protects pancreatic acinar cells from damage during acute pancreatitis. We have extended these observations to demonstrate that HSP70 is overexpressed in pancreatic cancer cells and plays a very prominent role in protecting cancer cells from cell death. While previous research focused primarily on the properties of the cancer cell, there has recently been increased understanding of the role of the tumor microenvironment (TME) in supporting cancer growth. Current grant is focused on understanding the role of HSP70 in TME on Pancreatic cancer progression.
Filed on March 28, 2018.
Tell us what you know about Salugna Banerjee's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Salugna Banerjee”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Salugna Banerjee | University of Miami School of Medicine | Conflict of Interest | Minneamrita Therapeutics | $10,000 - $19,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.